Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lysak, Zoreslava
NCT05422365: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults	Completed	3	32	RoW	Intravenous immunoglobulin (IVIG), 10% solution for infusion, Bioven, 10% solution for infusion	Biopharma Plasma LLC	Primary Immune Thrombocytopenia	12/23	12/23
Mukhanova, Yuliia
NCT05422365: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults	Completed	3	32	RoW	Intravenous immunoglobulin (IVIG), 10% solution for infusion, Bioven, 10% solution for infusion	Biopharma Plasma LLC	Primary Immune Thrombocytopenia	12/23	12/23
Karnabeda, Oksana
NCT05422365: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults	Completed	3	32	RoW	Intravenous immunoglobulin (IVIG), 10% solution for infusion, Bioven, 10% solution for infusion	Biopharma Plasma LLC	Primary Immune Thrombocytopenia	12/23	12/23